Featured Press Release

  • 3/21/17 8:00 am EDT

    Bendeka protected by 14 patents running from 2026 through 2033

    Thirteen Orange Book listed patents

    WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) (“Eagle” or “the Company”) today announced that three additional patents have been issued related to Bendeka by the United States Patent and Trademark Office (USPTO). Patent numbers 9,579,397 and 9,579,398 and 9,579,399 will expire March 2033. The USPTO has now issued or allowed a total of 14 patents in the Bendeka family of patents expiring from 2026 to 2033. The three newly issued patents willmore